Sanofi Shares: Underrated Growth Opportunity at a Discounted Price
Wednesday / 05/20/2026, 21:24 EST
Sanofi offers a rare blend of robust sales growth and low valuation. With a forward P/E under 9, the pharma giant presents a compelling margin of safety for long-term investors.
